A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Public ClinicalTrials.gov record NCT06809400. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single-Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to generate evidence of the safety, tolerability, and pharmacokinetics/pharmacodynamics of IV LY4006896 compared with placebo in healthy participants and participants with Parkinson's disease.
Study identification
- NCT ID
- NCT06809400
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 18, 2025 (Actual)
- Primary completion
- Oct 2028 (Estimated)
- Completion
- Oct 2028 (Estimated)
- Last update posted
- Oct 14, 2026
2025 – 2028
United States locations
- U.S. sites
- 11
- U.S. states
- 5
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Collaborative Neuroscience Network - CNS | Los Alamitos | California | 90720 | Recruiting |
| K2 Medical Research, LLC | Maitland | Florida | 32751 | Completed |
| Aqualane Clinical Research | Naples | Florida | 34105 | Recruiting |
| Charter Research | Orlando | Florida | 32803 | Recruiting |
| Progressive Medical Research | Port Orange | Florida | 32127 | Recruiting |
| K2 Medical Research, LLC | The Villages | Florida | 32159 | Recruiting |
| Charter Research | The Villages | Florida | 32162-2698 | Recruiting |
| QUEST Research Institute | Farmington Hills | Michigan | 48334 | Recruiting |
| PPD Development, LP | Austin | Texas | 78744 | Recruiting |
| Evergreen Health Research | Kirkland | Washington | 98034 | Not yet recruiting |
| Inland Northwest Research | Spokane | Washington | 99202 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06809400, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2026 · Synced Nov 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06809400 live on ClinicalTrials.gov.